These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

939 related items for PubMed ID: 8061027

  • 1. Deleterious effects of cardiopulmonary bypass on early graft function after single lung allotransplantation: evaluation of a heparin-coated bypass circuit.
    Francalancia NA, Aeba R, Yousem SA, Griffith BP, Marrone GC.
    J Heart Lung Transplant; 1994; 13(3):498-507. PubMed ID: 8061027
    [Abstract] [Full Text] [Related]

  • 2. Heparin-coated circuits reduce complement activation and inflammatory response to cardiopulmonary bypass.
    Tamim M, Demircin M, Guvener M, Peker O, Yilmaz M.
    Panminerva Med; 1999 Sep; 41(3):193-8. PubMed ID: 10568115
    [Abstract] [Full Text] [Related]

  • 3. Retrograde flush and cold storage for twenty-two to twenty-five hours lung preservation with and without prostaglandin E1.
    Chen CZ, Gallagher RC, Ardery P, Dyckman W, Donabue S, Low HB.
    J Heart Lung Transplant; 1997 Jun; 16(6):658-66. PubMed ID: 9229296
    [Abstract] [Full Text] [Related]

  • 4. Heparinized cardiopulmonary bypass and full heparin dose marginally improve clinical performance.
    Ovrum E, Am Holen E, Tangen G, Ringdal MA.
    Ann Thorac Surg; 1996 Oct; 62(4):1128-33. PubMed ID: 8823101
    [Abstract] [Full Text] [Related]

  • 5. The impact of heparin-coated circuits on hemodynamics during and after cardiopulmonary bypass.
    de Vroege R, Huybregts R, van Oeveren W, van Klarenbosch J, Linley G, Mutlu J, Jansen E, Hack E, Eijsman L, Wildevuur C.
    Artif Organs; 2005 Jun; 29(6):490-7. PubMed ID: 15926987
    [Abstract] [Full Text] [Related]

  • 6. Preharvest nitroprusside flush improves posttransplantation lung function.
    Fujino S, Nagahiro I, Yamashita M, Yano M, Schmid RA, Cooper JD, Patterson GA.
    J Heart Lung Transplant; 1997 Oct; 16(10):1073-80. PubMed ID: 9361250
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of heparin-coated circuits with full heparin dose strategy.
    Sinci V, Kalaycioglu S, Gunaydin S, Imren Y, Gokgoz L, Soncul H, Ersoz A.
    Ann Thorac Cardiovasc Surg; 1999 Jun; 5(3):156-63. PubMed ID: 10413761
    [Abstract] [Full Text] [Related]

  • 8. Controlled pressure reperfusion of rat pulmonary grafts yields improved function after twenty-four-hours' cold storage in University of Wisconsin solution.
    Hopkinson DN, Bhabra MS, Odom NJ, Bridgewater BJ, Van Doorn CA, Hooper TL.
    J Heart Lung Transplant; 1996 Mar; 15(3):283-90. PubMed ID: 8777212
    [Abstract] [Full Text] [Related]

  • 9. Cardiopulmonary bypass without systemic heparinization. Performance of heparin-coated oxygenators in comparison with classic membrane and bubble oxygenators.
    von Segesser LK, Turina M.
    J Thorac Cardiovasc Surg; 1989 Sep; 98(3):386-96. PubMed ID: 2770320
    [Abstract] [Full Text] [Related]

  • 10. Hypertonic-hyperoncotic solutions improve cardiac function in children after open-heart surgery.
    Schroth M, Plank C, Meissner U, Eberle KP, Weyand M, Cesnjevar R, Dötsch J, Rascher W.
    Pediatrics; 2006 Jul; 118(1):e76-84. PubMed ID: 16751617
    [Abstract] [Full Text] [Related]

  • 11. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y.
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [Abstract] [Full Text] [Related]

  • 12. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V, Noyan T, Ozcan S, Melek Y, Ekim H, Yakut C.
    J Card Surg; 2006 Feb; 21(6):572-7. PubMed ID: 17073955
    [Abstract] [Full Text] [Related]

  • 13. Beneficial effects of Duraflo II heparin-coated circuits on postperfusion lung dysfunction.
    Ranucci M, Cirri S, Conti D, Ditta A, Boncilli A, Frigiola A, Menicanti L.
    Ann Thorac Surg; 1996 Jan; 61(1):76-81. PubMed ID: 8561642
    [Abstract] [Full Text] [Related]

  • 14. Heparin-coated versus uncoated extracorporeal circuit in patients undergoing coronary artery bypass graft surgery.
    Oliver WC, Nuttall GA, Ereth MH, Santrach PJ, Buda DA, Schaff HV.
    J Cardiothorac Vasc Anesth; 2003 Apr; 17(2):165-70. PubMed ID: 12698396
    [Abstract] [Full Text] [Related]

  • 15. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O, Fosse E, Dregelid E, Brockmeier V, Andersson C, Høgåsen K, Venge P, Mollnes TE, Kierulf P.
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [Abstract] [Full Text] [Related]

  • 16. Preservation of the lung: comparison of flush perfusion with cold modified blood and core cooling by cardiopulmonary bypass.
    Locke TJ, Hooper TL, Flecknell PA, McGregor CG.
    J Heart Lung Transplant; 1991 Oct; 10(1 Pt 1):1-8. PubMed ID: 1706628
    [Abstract] [Full Text] [Related]

  • 17. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L, Borowiec JW, Thelin S, Hultman J.
    Scand Cardiovasc J; 1997 Oct; 31(5):275-81. PubMed ID: 9406294
    [Abstract] [Full Text] [Related]

  • 18. Effects of prostaglandin E1 in twelve-hour lung preservation.
    Bonser RS, Fragomeni LS, Jamieson SW, Fischel RJ, Harris KM, Edwards BJ, Rotenberg D, Kaye MP.
    J Heart Lung Transplant; 1991 Oct; 10(2):310-5; discussion 316. PubMed ID: 2031930
    [Abstract] [Full Text] [Related]

  • 19. Modified low-flow ultrafiltration ameliorates hemodynamics and early graft function and reduces blood loss in living-donor lobar lung transplantation.
    Kotani Y, Honjo O, Goto K, Fujita Y, Ito A, Nakakura M, Kawada M, Sano S, Kotani K, Date H.
    J Heart Lung Transplant; 2009 Apr; 28(4):340-6. PubMed ID: 19332260
    [Abstract] [Full Text] [Related]

  • 20. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 47.